However, some studies show that NTRK3 is a potential tumor suppressor gene in colorectal cancer [12, 25] and is also highly expressed in good-prognosis neuroblastomas as well as medulloblastomas [26, 27], but NTRK3 works as a oncogene in breast tumor [28]. The gene discussed is NTRK3; the disease is medulloblastoma.